Nifty

:

22620.40

Sensex

:

73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Login

Nifty
Sensex

:
:

22620.40
73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Aarey Drugs & Pharmaceuticals Ltd.

Trading

Rating :

56/99

BSE: 524412 | NSE: AAREYDRUGS

Watchlist

NSE BSE

54.40

26-Apr-2024

Open
High
Low
Previous Close

53.30
55.55
51.05
53.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

122637
66.71
68.00
27.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

154.07
40.77
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

190.28
N/A
1.18

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.69
3.39
6.34

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.24
-0.41
10.70

PAT CAGR (%)

10 Years
5 Years
3 Years

13.64
-10.43
-16.65

P:E (Median)

8 Years
5 Years
3 Years

15.21
12.87
20.71

P:BV (Average)

8 Years
5 Years
3 Years

0.80
0.80
0.88

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.19
8.51
10.26

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 76.48 62.47 22.43% 57.83 76.26 -24.17% 50.96 118.84 -57.12% 158.18 120.25 31.54%
Expenses 73.77 60.94 21.05% 55.98 71.99 -22.24% 49.62 117.94 -57.93% 160.36 118.38 35.46%
EBITDA 2.70 1.53 76.47% 1.85 4.27 -56.67% 1.34 0.90 48.89% -2.18 1.86 -
EBIDTM 3.53% 2.45% 3.19% 5.60% 2.63% 0.76% -1.38% 1.55%
Other Income 0.29 0.48 -39.58% 0.84 -0.94 - 0.70 0.85 -17.65% 5.54 1.14 385.96%
Interest 1.06 0.71 49.30% 1.27 0.59 115.25% 0.89 0.55 61.82% 1.02 0.59 72.88%
Depreciation 0.47 0.55 -14.55% 0.41 0.42 -2.38% 0.42 0.41 2.44% 0.20 0.43 -53.49%
PBT 1.46 0.75 94.67% 1.01 2.32 -56.47% 0.73 0.80 -8.75% 2.15 1.98 8.59%
Tax -0.44 -0.25 - 0.22 0.21 4.76% 0.00 0.00 0 1.78 2.73 -34.80%
PAT 1.91 1.00 91.00% 0.78 2.12 -63.21% 0.73 0.80 -8.75% 0.36 -0.75 -
PATM 2.49% 1.60% 1.36% 2.78% 1.42% 0.67% 0.23% -0.63%
EPS 0.68 0.35 94.29% 0.28 0.75 -62.67% 0.26 0.28 -7.14% 0.13 -0.27 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 343.45 418.96 492.76 348.42 300.09 354.71 348.63 395.97 246.03 213.44 199.73 Net Sales Growth -9.10% -14.98% 41.43% 16.11% -15.40% 1.74% -11.96% 60.94% 15.27% 6.86% Cost Of Goods Sold 333.65 397.53 466.12 334.50 290.18 340.97 337.37 382.99 241.99 209.67 194.54 Gross Profit 9.80 21.42 26.65 13.92 9.91 13.73 11.27 12.98 4.03 3.77 5.19 GP Margin 2.85% 5.11% 5.41% 4.00% 3.30% 3.87% 3.23% 3.28% 1.64% 1.77% 2.60% Total Expenditure 339.73 411.23 481.37 343.77 296.86 346.82 340.99 386.36 245.02 212.08 198.40 Power & Fuel Cost - 0.03 0.04 0.00 0.01 0.04 0.04 0.04 0.07 0.03 0.52 % Of Sales - 0.01% 0.01% 0% 0.00% 0.01% 0.01% 0.01% 0.03% 0.01% 0.26% Employee Cost - 0.63 0.67 0.20 0.29 0.37 0.35 0.34 0.26 0.26 0.41 % Of Sales - 0.15% 0.14% 0.06% 0.10% 0.10% 0.10% 0.09% 0.11% 0.12% 0.21% Manufacturing Exp. - 7.75 8.00 4.55 1.54 1.94 0.07 0.00 0.77 0.46 0.63 % Of Sales - 1.85% 1.62% 1.31% 0.51% 0.55% 0.02% 0% 0.31% 0.22% 0.32% General & Admin Exp. - 3.09 3.42 2.00 1.40 1.19 1.88 1.47 0.95 0.88 1.07 % Of Sales - 0.74% 0.69% 0.57% 0.47% 0.34% 0.54% 0.37% 0.39% 0.41% 0.54% Selling & Distn. Exp. - 1.30 2.15 1.86 3.37 2.28 1.12 1.43 0.91 0.72 1.11 % Of Sales - 0.31% 0.44% 0.53% 1.12% 0.64% 0.32% 0.36% 0.37% 0.34% 0.56% Miscellaneous Exp. - 0.90 0.97 0.66 0.06 0.03 0.17 0.10 0.07 0.07 1.11 % Of Sales - 0.21% 0.20% 0.19% 0.02% 0.01% 0.05% 0.03% 0.03% 0.03% 0.06% EBITDA 3.71 7.73 11.39 4.65 3.23 7.89 7.64 9.61 1.01 1.36 1.33 EBITDA Margin 1.08% 1.85% 2.31% 1.33% 1.08% 2.22% 2.19% 2.43% 0.41% 0.64% 0.67% Other Income 7.37 2.73 2.67 7.01 6.69 4.34 3.18 3.34 3.14 2.59 1.58 Interest 4.24 2.87 2.04 2.44 1.79 2.23 1.92 4.33 1.72 1.49 0.95 Depreciation 1.50 1.57 1.99 0.92 0.89 1.01 0.71 0.64 0.62 1.05 0.62 PBT 5.35 6.01 10.04 8.30 7.24 8.99 8.19 7.98 1.81 1.41 1.34 Tax 1.56 2.24 3.48 1.79 1.45 2.44 2.01 2.50 0.52 0.32 0.29 Tax Rate 29.16% 37.27% 34.66% 21.57% 20.03% 27.14% 24.54% 31.33% 28.73% 22.70% 21.64% PAT 3.78 3.77 6.55 6.51 5.79 6.54 6.18 5.47 1.29 1.09 1.05 PAT before Minority Interest 3.78 3.77 6.55 6.51 5.79 6.54 6.18 5.47 1.29 1.09 1.05 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.10% 0.90% 1.33% 1.87% 1.93% 1.84% 1.77% 1.38% 0.52% 0.51% 0.53% PAT Growth 19.24% -42.44% 0.61% 12.44% -11.47% 5.83% 12.98% 324.03% 18.35% 3.81% EPS 1.35 1.34 2.33 2.32 2.06 2.33 2.20 1.95 0.46 0.39 0.37

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 117.41 113.64 98.86 92.35 86.55 80.24 49.19 36.70 35.41 34.52 Share Capital 25.38 25.38 23.38 23.38 23.38 23.38 18.08 16.81 16.81 16.81 Total Reserves 89.71 85.94 73.16 66.65 60.85 54.55 30.07 19.88 18.59 17.71 Non-Current Liabilities 5.78 4.80 3.37 1.46 1.53 1.35 1.61 0.09 0.00 0.01 Secured Loans 4.36 3.34 0.00 0.02 0.04 0.06 0.07 0.09 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Long Term Provisions 0.00 0.00 1.81 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 168.14 126.74 130.80 100.28 57.63 88.19 91.70 88.21 79.54 72.35 Trade Payables 127.33 109.66 110.34 77.75 37.28 77.58 74.55 71.95 67.14 64.08 Other Current Liabilities 2.18 1.03 0.78 2.00 0.37 4.26 4.38 0.63 0.28 1.54 Short Term Borrowings 33.36 10.82 18.02 17.87 16.12 3.18 10.32 14.45 11.02 5.70 Short Term Provisions 5.28 5.23 1.66 2.66 3.86 3.18 2.45 1.19 1.09 1.03 Total Liabilities 291.33 245.18 233.03 194.09 145.71 169.78 142.50 125.00 114.95 106.88 Net Block 13.94 14.47 14.26 12.30 12.27 11.71 12.15 7.85 5.89 4.38 Gross Block 33.17 32.13 29.93 27.05 26.13 24.56 24.28 19.35 16.77 14.01 Accumulated Depreciation 19.23 17.66 15.67 14.75 13.86 12.85 12.14 11.50 10.88 9.62 Non Current Assets 20.72 26.35 14.66 12.74 12.72 12.50 12.61 8.29 6.33 5.16 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.34 0.00 0.00 0.00 0.33 Non Current Investment 0.40 0.40 0.40 0.44 0.44 0.44 0.44 0.44 0.44 0.44 Long Term Loans & Adv. 6.37 9.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Other Non Current Assets 0.01 2.40 0.00 0.00 0.01 0.01 0.03 0.00 0.00 0.00 Current Assets 270.61 218.82 218.38 181.34 132.99 157.29 129.88 116.71 108.59 101.66 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 28.82 13.68 18.46 17.00 21.25 14.77 5.21 2.08 4.17 5.13 Sundry Debtors 189.78 136.28 162.01 96.13 105.74 95.30 81.86 72.48 66.71 64.85 Cash & Bank 0.71 0.19 0.65 0.50 0.37 3.39 1.04 1.62 0.17 0.85 Other Current Assets 51.30 0.66 2.81 1.85 5.63 43.83 41.78 40.53 37.53 30.83 Short Term Loans & Adv. 50.49 68.00 34.45 65.86 4.59 43.72 41.78 40.53 37.53 27.34 Net Current Assets 102.47 92.08 87.57 81.07 75.36 69.10 38.18 28.49 29.05 29.31 Total Assets 291.33 245.17 233.04 194.08 145.71 169.79 142.49 125.00 114.95 106.88

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -1.28 0.50 5.48 2.86 0.69 -20.35 0.62 5.66 3.25 -0.42 PBT 6.01 10.03 8.30 7.24 8.99 8.19 7.98 1.81 1.41 1.34 Adjustment 4.44 3.99 3.35 2.68 3.24 2.63 5.02 2.37 2.57 1.60 Changes in Working Capital -9.45 -9.93 -4.51 -5.56 -9.29 -28.56 -10.27 1.48 -0.73 -3.36 Cash after chg. in Working capital 1.00 4.09 7.14 4.36 2.94 -17.74 2.72 5.66 3.25 -0.42 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.28 -3.59 -1.66 -1.50 -2.25 -2.61 -2.10 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.44 -3.21 -2.88 -0.92 -1.23 -0.60 -4.96 -2.58 -2.43 1.86 Net Fixed Assets -1.04 -2.20 -2.88 -0.92 -1.23 -0.62 -4.93 -2.58 -2.43 -0.93 Net Investments 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.00 0.00 2.79 Others 1.48 -1.01 -0.04 0.00 0.00 0.02 -0.03 0.00 0.00 0.00 Cash from Financing Activity 1.35 2.25 -2.45 -1.80 -2.48 23.31 3.75 -1.63 -1.50 -1.10 Net Cash Inflow / Outflow 0.51 -0.46 0.15 0.13 -3.02 2.35 -0.58 1.45 -0.68 0.34 Opening Cash & Equivalents 0.19 0.65 0.50 0.37 3.39 1.04 1.62 0.00 0.85 0.51 Closing Cash & Equivalent 0.71 0.19 0.65 0.50 0.37 3.39 1.04 1.62 0.17 0.85

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 45.34 43.85 41.29 38.50 36.02 33.33 26.63 21.82 21.04 20.49 ROA 1.41% 2.74% 3.05% 3.41% 4.15% 3.96% 4.09% 1.07% 0.98% 0.98% ROE 3.33% 6.31% 6.98% 6.65% 8.07% 9.80% 12.90% 3.58% 3.12% 3.10% ROCE 6.27% 9.87% 9.46% 8.48% 12.05% 14.14% 22.21% 7.23% 6.69% 5.83% Fixed Asset Turnover 12.83 15.88 12.23 11.29 14.00 14.30 18.15 13.62 13.87 14.75 Receivable days 142.04 110.48 135.22 122.77 103.43 92.55 71.13 103.25 112.49 119.94 Inventory Days 18.51 11.91 18.57 23.26 18.53 10.44 3.36 4.63 7.95 11.56 Payable days 108.80 86.14 102.62 71.79 59.35 79.48 68.80 104.65 113.37 119.67 Cash Conversion Cycle 51.75 36.24 51.17 74.24 62.62 23.51 5.69 3.23 7.07 11.83 Total Debt/Equity 0.33 0.13 0.19 0.20 0.19 0.04 0.22 0.40 0.31 0.17 Interest Cover 3.10 5.93 4.40 5.06 5.03 5.27 2.84 2.06 1.95 2.42

Top Investors:

india opportunities growth fund ltd - pinewood strategy

c g krishnamurthy

chetan kiritbhai mehta

black hawk properties pvt ltd

zil penil doshi

vijaykumar b shah

Annual Reports:

News Update:

Aarey Drugs & Pharma - Quarterly Results
14th Feb 2024, 16:26 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback